Henson Glen J, van der Mei Ingrid, Taylor Bruce V, Claflin Suzi B, Palmer Andrew J, Chen Gang, Campbell Julie A
Menzies Institute for Medical Research, University of Tasmania, Hobart, Tasmania, Australia.
Centre for Health Economics, Monash University, Caulfield East, Victoria, Australia.
Brain Behav. 2025 Jan;15(1):e70210. doi: 10.1002/brb3.70210.
Studies have shown that people living with multiple sclerosis (PwMS) were substantially impacted by the COVID-19 pandemic. However, no study has compared the overall health-related quality of life impact of the COVID-19 pandemic on PwMS and the general population. Differences would have implications for crises/pandemic management policies. This study aimed to compare the prevalence and health-related quality of life impact of COVID-19-related adversity (such as deteriorations in mental or physical health) in PwMS and the general population.
Cross-sectional data were obtained from the How Is Your Life Australian general population study (comprising subsamples with and without chronic disease) and the Australian MS Longitudinal Study from August to October 2020. Health-related quality of life was measured using health state utilities (HSUs; represented on a 0 [death] to 1 [full health] scale) generated by the EQ-5D-5L-Psychosocial. COVID-19-related adversity was measured via specialized survey items. Descriptive and multivariable regression analyses were conducted.
A total of 1020 general population individuals and 1635 MS participants entered the study (mean age 52.4 and 58.4; female 52.4% and 80.2%, respectively). COVID-19-related adversity prevalence was higher among PwMS compared to the general population with and without chronic diseases (PR: 1.430 [CI: 1.153, 1.774] and PR: 1.90 [CI: 1.56, 2.32], respectively). However, the HSU impact of COVID-19-related adversity was not dependent on disease status (p > 0.20, test for interaction).
This study found that PwMS were more likely to experience COVID-19-related adversity compared to the general population, though the health-related quality-of-life impact was similar. This demonstrates that PwMS require additional support during national and global crises.
研究表明,多发性硬化症患者(PwMS)受到了新冠疫情的重大影响。然而,尚无研究比较新冠疫情对PwMS和普通人群总体健康相关生活质量的影响。差异将对危机/疫情管理政策产生影响。本研究旨在比较PwMS和普通人群中与新冠相关的逆境(如心理健康或身体健康恶化)的患病率及其对健康相关生活质量的影响。
横断面数据取自2020年8月至10月的澳大利亚普通人群生活状况研究(包括有和没有慢性病的子样本)以及澳大利亚多发性硬化症纵向研究。使用EQ-5D-5L-心理社会量表生成的健康状态效用值(HSUs;范围从0[死亡]到1[完全健康])来衡量健康相关生活质量。通过专门的调查项目来衡量与新冠相关的逆境。进行了描述性和多变量回归分析。
共有1020名普通人群个体和1635名多发性硬化症参与者进入研究(平均年龄分别为52.4岁和58.4岁;女性分别占52.4%和80.2%)。与患有和未患有慢性病的普通人群相比,PwMS中与新冠相关的逆境患病率更高(PR分别为1.430[CI:1.153,1.774]和PR为1.90[CI:1.56,2.32])。然而,与新冠相关的逆境对HSU的影响并不取决于疾病状态(p>0.20,交互作用检验)。
本研究发现,与普通人群相比,PwMS更有可能经历与新冠相关的逆境,尽管对健康相关生活质量的影响相似。这表明在国家和全球危机期间,PwMS需要额外的支持。